Huntemann N[au] - Search Results

Year	Number of Results
2011	1
2012	2
2014	2
2016	3
2018	1
2019	1
2020	3
2021	7
2022	7

1

Autobalanced Ramsey Spectroscopy.

Sanner C, Huntemann N, Lange R, Tamm C, Peik E. Sanner C, et al. Among authors: huntemann n. Phys Rev Lett. 2018 Feb 2;120(5):053602. doi: 10.1103/PhysRevLett.120.053602. Phys Rev Lett. 2018. PMID: 29481175

2

Improved Limits for Violations of Local Position Invariance from Atomic Clock Comparisons.

Lange R, Huntemann N, Rahm JM, Sanner C, Shao H, Lipphardt B, Tamm C, Weyers S, Peik E. Lange R, et al. Among authors: huntemann n. Phys Rev Lett. 2021 Jan 8;126(1):011102. doi: 10.1103/PhysRevLett.126.011102. Phys Rev Lett. 2021. PMID: 33480794

3

Crosstalk of Microorganisms and Immune Responses in Autoimmune Neuroinflammation: A Focus on Regulatory T Cells.

Schroeter CB, Huntemann N, Bock S, Nelke C, Kremer D, Pfeffer K, Meuth SG, Ruck T. Schroeter CB, et al. Among authors: huntemann n. Front Immunol. 2021 Oct 7;12:747143. doi: 10.3389/fimmu.2021.747143. eCollection 2021. Front Immunol. 2021. PMID: 34691057 Free PMC article. Review.

4

Optical clock comparison for Lorentz symmetry testing.

Sanner C, Huntemann N, Lange R, Tamm C, Peik E, Safronova MS, Porsev SG. Sanner C, et al. Among authors: huntemann n. Nature. 2019 Mar;567(7747):204-208. doi: 10.1038/s41586-019-0972-2. Epub 2019 Mar 13. Nature. 2019. PMID: 30867608

5

Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Huntemann N, Rolfes L, Pawlitzki M, Ruck T, Pfeuffer S, Wiendl H, Meuth SG. Huntemann N, et al. Drugs. 2021 Jun;81(9):1031-1063. doi: 10.1007/s40265-021-01526-w. Epub 2021 Jun 4. Drugs. 2021. PMID: 34086251 Free PMC article. Review.

6

Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Rolfes L, Pawlitzki M, Pfeuffer S, Huntemann N, Wiendl H, Ruck T, Meuth SG. Rolfes L, et al. Among authors: huntemann n. BioDrugs. 2020 Oct;34(5):587-610. doi: 10.1007/s40259-020-00435-w. BioDrugs. 2020. PMID: 32785877 Free PMC article. Review.

7

Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis.

Vogelsang A, Eichler S, Huntemann N, Masanneck L, Böhnlein H, Schüngel L, Willison A, Loser K, Nieswandt B, Kehrel BE, Zarbock A, Göbel K, Meuth SG. Vogelsang A, et al. Among authors: huntemann n. Int J Mol Sci. 2021 Sep 14;22(18):9915. doi: 10.3390/ijms22189915. Int J Mol Sci. 2021. PMID: 34576080 Free PMC article.

8

Coherent Excitation of the Highly Forbidden Electric Octupole Transition in ^{172}Yb^{+}.

Fürst HA, Yeh CH, Kalincev D, Kulosa AP, Dreissen LS, Lange R, Benkler E, Huntemann N, Peik E, Mehlstäubler TE. Fürst HA, et al. Among authors: huntemann n. Phys Rev Lett. 2020 Oct 16;125(16):163001. doi: 10.1103/PhysRevLett.125.163001. Phys Rev Lett. 2020. PMID: 33124859

9

Lifetime of the ^{2}F_{7/2} Level in Yb^{+} for Spontaneous Emission of Electric Octupole Radiation.

Lange R, Peshkov AA, Huntemann N, Tamm C, Surzhykov A, Peik E. Lange R, et al. Among authors: huntemann n. Phys Rev Lett. 2021 Nov 19;127(21):213001. doi: 10.1103/PhysRevLett.127.213001. Phys Rev Lett. 2021. PMID: 34860090

10

Eculizumab versus rituximab in generalised myasthenia gravis.

Nelke C, Schroeter CB, Stascheit F, Pawlitzki M, Regner-Nelke L, Huntemann N, Arat E, Öztürk M, Melzer N, Mergenthaler P, Gassa A, Stetefeld H, Schroeter M, Berger B, Totzeck A, Hagenacker T, Schreiber S, Vielhaber S, Hartung HP, Meisel A, Wiendl H, Meuth SG, Ruck T. Nelke C, et al. Among authors: huntemann n. J Neurol Neurosurg Psychiatry. 2022 May;93(5):548-554. doi: 10.1136/jnnp-2021-328665. Epub 2022 Mar 4. J Neurol Neurosurg Psychiatry. 2022. PMID: 35246490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results